Industry news

FDA approves world’s first RSV vaccine for use in over 60s

By Catrin Jackson2023-05-10T11:42:00

RSV - United_States_Centers_for_Disease_Control_and_Prevention_logo

Arexvy has been approved for individuals aged 60 years and older

 This is member-only content

To read this article, SIGN IN NOW if you are a TOPRA member.

 

Not a TOPRA member yet? Join our global community.

Five great reasons to become a TOPRA member:

  1. Great savings on our events and training.
  2. Be part of our dynamic international community.
  3. Contribute to the profession.
  4. Grow your skills and knowledge.
  5. Take your career to the next level.

Become a member today!

Have you heard what you’re missing? Listen now to the RegRapPod podcast show, for free!